Blog
GESA recommendation: Faecal Calprotectin tests
The Gastroenterological Society of Australia (GESA) Led Application for faecal calprotectin for the monitoring of disease activity in patients with inflammatory bowel disease was approved by Medical Services Advisory Committee (MSAC) on 6 February 2025.
IBD and diet – patient questionnaire
IBD and diet – patient questionnaire Monash Health Gastroenterology researchers are conducting a survey on the effects of diet on…
Media coverage: IBD State of the Nation report
ABC: Inflammatory bowel disease rates increasing in Australia, costing the economy billions Author: Liana Walker “Australians living with inflammatory bowel…
Notice: CCA services closed Dec 21 – Jan 5
CCA’s office and services will be closed for the holidays from December 21 to January 5. This includes our Helpline and…
CCA CEO contributes to Abbvie Working Well report
A new AbbVie report has found that, of the one in two Australians living with a chronic health condition, over a third have left a job due to their condition.
Collective 202 Study
Patients can find locations in Australia by visiting Study Details | VE202 in Patients with Mild-to-Moderate Ulcerative Colitis | ClinicalTrials.gov
Crohn’s and Colitis Australia Joins Coalition to Advocate for Increased Funding for Preventive Health
Today, Crohn’s and Colitis Australia (CCA), alongside almost 20 other leading consumer health organisations, proudly joins the newly formed Coalition for Preventative Health Funding. The Coalition is calling on the federal government to commit to greater investment in Australia’s preventive health efforts.
Inform our Women’s Health and IBD video resource
As part of the Young Adult Support program, CCA is working on a new video resource dedicated to women’s health…
Have you used our translated resources? We want to hear from you
We currently have funding from the Australian Government to increase our offering of IBD resources in other languages. We want…
PBS listing of Velsipity for treatment of UC
PBS listing of Velsipity for treatment of UC Pfizer Australia has announced the reimbursement of its oral S1P receptor modulator…
Expanded access to funded shingles vaccine
Expanded access to funded shingles vaccine The federal government has expanded access to the shingles vaccine to cover individuals aged…
Ticker LFC interview – CCA CEO Leanne Raven
Watch the full Ticker News interview with CCA CEO Leanne Raven below